R. Harrigan

发表

Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.

A. Wensing, B. Larder, A. Revell, 2010, The Journal of antimicrobial chemotherapy.

The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan

S. Hammer, S. Yerly, A. Zolopa, 2000, Antiviral therapy.

The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy

Brendan Larder, Lidia Ruiz, Andrew Revell, 2007, Antiviral therapy.

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH S

R. Kaiser, J. Gatell, K. Ruxrungtham, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade

C. Archibald, J. Ho, J. Joy, 2020, PloS one.

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy

C. Katlama, S. Staszewski, V. Miller, 2000, AIDS.

Hepatitis C testing in Canada: don’t leave baby boomers behind

Julio S. G. Montaner, J. Joy, E. Wood, 2017, Canadian Medical Association Journal.

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

Mark Howison, R. Paredes, G. Van Domselaar, 2020, Scientific Reports.

Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.

J. Montaner, P. Sereda, J. Min, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Expanded Highly Active Antiretroviral Therapy Coverage Among HIV-Positive Drug Users to Improve Individual and Public Health Outcomes

R. Hogg, J. Montaner, E. Wood, 2010, Journal of acquired immune deficiency syndromes.

Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction

S. Mallal, J. Montaner, M. Cavassini, 2007 .

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

G. Dore, A. Howe, J. George, 2020, Hepatology communications.

Antiretroviral therapy: 'the state of the art'.

R. Hogg, J. Montaner, M. O’Shaughnessy, 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load

A. Wensing, A. Poon, C. Brumme, 2017, The Journal of antimicrobial chemotherapy.

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

R. Shafer, R. Paredes, J. Montaner, 2014, AIDS.

Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.

F. Ceccherini‐Silberstein, B. Clotet, J. Martinez-Picado, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Infection With Different HIV Subtypes Is Associated With CD4 Activation-Associated Dysfunction and Apoptosis

Jeffrey N. Martin, D. Bangsberg, R. Harrigan, 2009, Journal of acquired immune deficiency syndromes.

Alarming rate of transmitted drug resistance mutations and genetic diversity in newly HIV-1-infected patients in Benin

R. Harrigan, N. Vidal, C. Touré‐Kâne, 2020 .

Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus

Mark Howison, R. Paredes, G. Van Domselaar, 2018, Journal of the International AIDS Society.

Effects of vitamin A supplementation on viral load in HIV-1-infected pregnant women.

R. Harrigan, A. Coutsoudis, H. Coovadia, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool

B. Larder, J. Montaner, S. Emery, 2011, AIDS.

An alcoholic patient who continues to drink

M. Schechter, S. Strathdee, S. Currie, 2006, BMJ : British Medical Journal.

Results of External Quality Assessment for Proviral DNA Testing of HIV Tropism in the Maraviroc Switch Collaborative Study

R. Kaiser, A. Kelleher, S. Emery, 2013, Journal of Clinical Microbiology.

A dose‐ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment‐naive subjects

T. Harrer, C. Katlama, S. Staszewski, 1998, AIDS.

Temporal trends in the discontinuation of first-line antiretroviral therapy.

B. Yip, R. Hogg, R. Harrigan, 2014, The Journal of antimicrobial chemotherapy.

Mitochondrial Toxicity in the Era of HAART: Evaluating Venous Lactate and Peripheral Blood Mitochondrial DNA in HIV-Infected Patients Taking Antiretroviral Therapy

B. Yip, R. Hogg, J. Montaner, 2003, Journal of acquired immune deficiency syndromes.

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals

R. Hogg, J. Montaner, D. Moore, 2008, AIDS.

The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time

B. Yip, R. Hogg, J. Montaner, 2009, Journal of acquired immune deficiency syndromes.

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

B. Yip, R. Hogg, J. Montaner, 2002, Journal of acquired immune deficiency syndromes.

Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus

R. Harrigan, S. Read, M. Gomez, 2020 .

Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore

Andrew D Smith, Ji Hyun Choi, David Stoddart, 2020, bioRxiv.

High Degree of Interlaboratory Reproducibility of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Sequencing of Plasma Samples from Heavily Treated Patients

B. J. Betts, T. Merigan, R. Shafer, 2001, Journal of Clinical Microbiology.

Antiretroviral treatment in 1998

R. Hogg, J. Montaner, J. Raboud, 1998, The Lancet.

HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: descriptive analysis from 284 patients under treatment failure.

J. Montaner, H. Salomón, R. Harrigan, 2004, AIDS research and human retroviruses.

Phylogenetic surveillance of travel-related Zika virus infections through whole-genome sequencing methods

Muhammad Morshed, Jeffrey B. Joy, Kimia Kamelian, 2019, Scientific Reports.

A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity

S. Kwok, R. Harrigan, R. Resnick, 1997, Journal of clinical microbiology.

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance.

Soriano, K. Hertogs, F. Brun-Vézinet, 2001, AIDS.

A Made in Canada Strategy to Stop HIV and AIDS

Julio S. G. Montaner, E. Wood, T. Kerr, 2010 .

Measuring viral load in the clinical setting.

R. Harrigan, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Laboratory Guidelines for the Practical Use of HIV Drug Resistance Tests in Patient Follow-Up

K. Hertogs, B. Larder, B. Clotet, 2001, Antiviral therapy.

American Journal of Epidemiology Practice of Epidemiology Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated with Antiretroviral Drugs in North America

Richard D Moore, J. Goedert, B. Lau, 2022 .

Towards detecting the human immunodeficiency virus using microcantilever sensors

Richard Harrigan, Abdullah Alodhayb, R. Harrigan, 2013 .

Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies

R. Harrigan, M Tisdale, M. Tisdale, 2000, AIDS.

Tenofovir and Emtricitabine Resistance among Antiretroviral-Naive Patients in the Canadian Observational Cohort Collaboration: Implications for PrEP

R. Hogg, J. Montaner, A. Burchell, 2019, Antiviral therapy.

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2006, Antimicrobial Agents and Chemotherapy.

Suboptimal use of HIV drug resistance testing in a universal health-care setting

Kimberly A. Fernandes, R. Hogg, R. Harrigan, 2011, AIDS care.

The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study.

A. Mocroft, R. Hogg, C. Sabin, 2014, CMAJ open.

Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.

B. Yip, R. Hogg, J. Montaner, 2005, The Journal of infectious diseases.

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future

J. Montaner, C. Cohen, B. Nosyk, 2012, AIDS research and treatment.

Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay

J. Montaner, R. Harrigan, V. Lima, 2009, Journal of acquired immune deficiency syndromes.

A Prospective Randomized Controlled Trial of Structured Treatment Interruption in HIV-Infected Patients Failing Highly Active Antiretroviral Therapy (Canadian HIV Trials Network Study 164)

J. Singer, B. Conway, J. Macleod, 2007, Journal of acquired immune deficiency syndromes.

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2000, AIDS.

Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: Determining clinical markers and exploring social pathways

A. Levy, B. Yip, R. Hogg, 2008, AIDS care.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis

J. Sterne, A. Mocroft, P. Reiss, 2016, AIDS.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance

Jerome H. Kim, M. Poljak, R. Shafer, 2015 .

Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118.

B. Larder, S. Bloor, M. Zazzi, 2002, The Journal of infectious diseases.

RECall for Automated Genotypic Tropism Testing

R. Paredes, B. Clotet, C. Pou, 2013, Journal of Clinical Microbiology.

Testingfor Automated Genotypic Tropism

R. Paredes, B. Clotet, C. Pou, 2014 .

A Comparison of Three Computational Modelling Methods for the Prediction of Virological Response to Combination Hiv Therapy Author's Personal Copy

Brendan Larder, Dechao Wang, Lidia Ruiz, 2022 .

Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB

I. Sadowski, V. Simon, C. Brumme, 2014, Retrovirology.

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Sally S Bebawy, Richard D Moore, J. Goedert, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future

J. Montaner, C. Cohen, B. Nosyk, 2012, AIDS research and treatment.

P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA

J. Montaner, J. Joy, G. Dore, 2014 .

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

A. d’Arminio Monforte, B. Larder, J. Montaner, 2009, Artif. Intell. Medicine.

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.

J. Goedert, B. Lau, R. Hogg, 2011, American Journal of Epidemiology.

Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay

J. Montaner, R. Harrigan, V. Lima, 2009, Journal of acquired immune deficiency syndromes.

Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.

F. Ceccherini‐Silberstein, S. Aquaro, C. Perno, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.